Ramsay L Fuleihan Selected Research

atypical Severe combined immunodeficiency

1/2020

A case of aberrant CD8 T cell-restricted IL-7 signaling with a Janus kinase 3 defect-associated atypical severe combined immunodeficiency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ramsay L Fuleihan Research Topics

Disease

5	Infections 01/2022 - 05/2012
3	Primary Immunodeficiency Diseases 10/2022 - 07/2014
2	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 08/2019
2	Agammaglobulinemia (Hypogammaglobulinemia) 08/2019 - 01/2018
2	Reinfection 08/2019 - 01/2018
2	Lymphopenia (Lymphocytopenia) 01/2019 - 05/2012
2	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 12/2016 - 07/2014
2	Human Influenza (Influenza) 11/2016 - 05/2012
1	Respiratory Tract Infections (Respiratory Tract Infection) 10/2022
1	Pneumonia (Pneumonitis) 10/2022
1	Chronic Granulomatous Disease 01/2022
1	Bruton type agammaglobulinemia 01/2022
1	Eye Infections 01/2022
1	atypical Severe combined immunodeficiency 01/2020
1	Lung Diseases (Lung Disease) 01/2020
1	Central Nervous System Diseases (CNS Diseases) 08/2019
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 08/2019
1	Vasculitis (Vasculitides) 08/2019
1	Cytopenia 01/2018
1	Neutropenia 01/2018
1	Hemolytic Anemia 01/2018
1	Common Variable Immunodeficiency 01/2018
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2018
1	Neoplasms (Cancer) 11/2016
1	Fever (Fevers) 11/2016
1	Hyper-IgM Immunodeficiency Syndrome (Hyper-IgM Syndrome) 04/2014
1	Staphylococcal Skin Infections 05/2012
1	Job Syndrome (Hyper-IgE Syndrome) 05/2012
1	Immunologic Deficiency Syndromes 05/2012
1	Mycoses (Diseases, Fungus) 05/2012
1	Type 1 Hyper-IgM Immunodeficiency Syndrome 02/2002

Drug/Important Bio-Agent (IBA)

3	Immunoglobulins (Immunoglobulin)IBA 10/2022 - 08/2019
2	Immunoglobulin G (IgG)IBA 08/2019 - 05/2012
2	CD40 Ligand (CD40L)IBA 04/2014 - 02/2002
1	Immunoglobulin A (IgA)IBA 10/2022
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2022
1	Immunomodulating AgentsIBA 01/2022
1	NADP (NADPH)IBA 01/2022
1	Immunologic Factors (Immunomodulators)IBA 01/2022
1	Oxidoreductases (Dehydrogenase)IBA 01/2022
1	Oxygen (Dioxygen)IBA 01/2020
1	Interleukin-7 (Interleukin 7)IBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	Janus Kinase 3IBA 01/2020
1	Antiviral Agents (Antivirals)IBA 01/2020
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 08/2019
1	Rituximab (Mabthera)FDA Link 08/2019
1	Actins (F Actin)IBA 01/2019
1	Superoxides (Superoxide)IBA 01/2019
1	Immunoglobulin E (IgE)IBA 01/2018
1	Inosine Triphosphate (ITP)IBA 01/2018
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 12/2016
1	Immunoglobulin IsotypesIBA 04/2014
1	InterferonsIBA 05/2012
1	InterleukinsIBA 05/2012
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 05/2012
1	Complement System Proteins (Complement)IBA 05/2012
1	Toll-Like Receptors (Toll-Like Receptor)IBA 05/2012
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 05/2012

Therapy/Procedure

4	Therapeutics 10/2022 - 08/2019
1	Hematopoietic Stem Cell Transplantation 01/2022
1	Drug Therapy (Chemotherapy) 11/2016
1	Transplantation 07/2014
1	Cell Transplantation 07/2014